CONNAISSANCES RECENTES SUR LE MODE D'ACTION DES NEUROLEPTIQUESBARTHOLINI G.1978; ACTUAL. PHARMACOL.; FRA; DA. 1978; VOL. 30; PP. 35-47; BIBL. 41 REF.Article

GABA receptor agonists: pharmacological spectrum and therapeutic actionsBARTHOLINI, G.Medicinal research reviews (Print). 1985, Vol 5, Num 1, pp 55-75, issn 0198-6325Article

Pharmacology of the gabaergic system: effects of progabide, a GABA receptor agonistBARTHOLINI, G.Psychoneuroendocrinology. 1984, Vol 9, Num 2, pp 135-140, issn 0306-4530Article

DRUG-INDUCED CHANGES OF EPINEPHRINE TURNOVER IN THE RAT HYPOTHALAMUSSCATTON B; BARTHOLINI G.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 11; PP. 1161-1170; BIBL. 43 REF.Article

EVIDENCE FOR AN INTRASTRIATAL GABA-ERGIC INFLUENCE ON DOPAMINE NEURONES OF THE CAT.BARTHOLINI G; STADLER H.1977; NEUROPHARMACOLOGY; G.B.; DA. 1977; VOL. 16; NO 5; PP. 343-347; BIBL. 21 REF.Article

GAMMA -AMINOBUTYRIC ACID (GABA) RECEPTOR STIMULATION. IV: EFFECT OF PROGABIDE (SL 76002) AND THE OTHER GABAERGIC AGENTS ON ACETYLCHOLINE TURNOVER IN RAT BRAIN AREASSCATTON B; BARTHOLINI G.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 3; PP. 689-695; BIBL. 45 REF.Article

THE POTENTIAL OF GABA-MIMETICS IN THE THERAPY OF EXTRAPYRAMIDAL DISORDERSBARTHOLINI G; LLOYD KG.1980; J. NEUR. TRANSM., SUPPL.; AUT; DA. 1980; NO 16; PP. 229-238; BIBL. 3 P.Article

THE EFFECT OF METHIOTHEPIN ON CEREBRAL MONOAMINE NEURONSLLOYD KG; BARTHOLINI G.1974; ADV. BIOCHEM. PSYCHOPHARMACOL.; U.S.A.; DA. 1974; VOL. 10; PP. 305-309; BIBL. 15REF.Article

INCREASE IN STRIATAL ACETYLCHOLINE LEVELS BY GABAERGIC AGENTS: DEPENDENCE ON CORTICOSTRIATAL NEURONSSCATTON B; BARTHOLINI G.1980; BRAIN RES.; ISSN 0006-8993; NLD; DA. 1980; VOL. 200; NO 1; PP. 174-178; BIBL. 20 REF.Article

DEGENERATION AND REGENERATION OF ADRENERGIC NERVES IN MESENTERIC BLOOD VESSELS, IRIS AND ATRIUM OF THE RAT AFTER 6-HYDROXYDOPAMINE INJECTIONLOREZ HP; KUHN H; BARTHOLINI G et al.1975; J. NEUROCYTOL.; G.B.; DA. 1975; VOL. 4; NO 2; PP. 157-176; BIBL. 2PArticle

MONOAMINERGIC DRUGS: GENERAL PHARMACOLOGY = LES PRODUITS MONOAMINERGIQUES: PHARMACOLOGIE GENERALEHAEFELY W; BARTHOLINI G; PLETSCHER A et al.1976; PHARMACOL. AND THERAPEUT., B; G.B.; DA. 1976; VOL. 2; NO 1; PP. 185-218; BIBL. 10 P.Article

DRUG-INDUCED CHANGES OF STRIATAL CHOLINERGIC AND DOPAMINERGIC FUNCTIONS IN RATS WITH SPREADING DEPRESSION = MODIFICATIONS INDUITES PAR LES MEDICAMENTS DANS LES FONCTIONS CHOLINERGIQUES ET DOPAMINERGIQUES DU CORPS STRIE CHEZ DES RATS AVEC DEPRESSION DIFFUSEKELLER HH; BARTHOLINI G; PLETSCHER A et al.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 6; PP. 433-436; BIBL. 13REF.Serial Issue

DRUG-INDUCED CHANGES OF DOPAMINE TURNOVER IN STRIATUM AND LIMBIC SYSTEM OF THE RAT = MODIFICATIONS, INDUITES PAR LES MEDICAMENTS, DE RENOUVELLEMENT DE LA DOPAMINE DANS LE CORPS STRIE ET LE SYSTEME LIMBIQUE DU RATBARTHOLINI G; KELLER HH; PLETSCHER A et al.1975; J. PHARM. PHARMACOL.; G.B.; DA. 1975; VOL. 27; NO 6; PP. 439-442; BIBL. 14REF.Article

IN VIVO RELEASE OF ENDOGENOUS NEUROTRANSMITTERS IN CAT LIMBIC REGIONS: EFFECT OF CHLORPROMAZINE AND OF ELECTRICAL STIMULATION = LA LIBERATION IN VIVO DE NEUROTRANSMETTEURS ENDOGENES DANS LES REGIONS LIMBIQUES DU CHAT. EFFET DE LA CHLORPROMAZINE ET DE LA STIMULATION ELECTRIQUESTADLER H; GADEA CIRIA M; BARTHOLINI G et al.1975; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1975; VOL. 288; NO 1; PP. 1-6; BIBL. 1 P. 1/2Article

ENHANCEMENT OF CEREBRAL NORADRENALINE TURNOVER BY THYROTROPIN-RELEASING HORMONE = STIMULATION DU RENOUVELLEMENT DE LA NORADRENALINE CEREBRAL PAR L'HORMONE DE DECHARGE DE THYROTROPINEKELLER HH; BARTHOLINI G; PLETSCHER A et al.1974; NATURE; G.B.; DA. 1974; VOL. 248; NO 5448; PP. 528-529; BIBL. 17REF.Article

IN VIVO ENHANCEMENT OF TYROSINE HYDROXYLATION IN RAT STRIATUM BY TETRAHYDROBIOPTERIN = STIMULATION IN VIVO PAR LA TETRAHYDROBIOPTERINE DE L'HYDROXYLATION DE LA TYROSINE DANS LE CORPS STRIE DU RATKETTLER R; BARTHOLINI G; PLETSCHER A et al.1974; NATURE; G.B.; DA. 1974; VOL. 249; NO 5456; PP. 476-478; BIBL. 15REF.Article

THE METABOLIC PATHWAYS OF L-3-O-METHYLDOPABARTHOLINI G; KURUMA I; PLETSCHER A et al.1972; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1972; VOL. 183; NO 1; PP. 65-72; BIBL. 18 REF.Serial Issue

CORTICAL MODULATION OF STRIATAL FUNCTIONSCATTON B; WORMS P; LLOYD KG et al.1982; BRAIN RES.; ISSN 0006-8993; NLD; DA. 1982; VOL. 232; NO 2; PP. 331-343; BIBL. 48 REF.Article

CONSOMMATION CEREBRALE ET PERIPHERIQUE DE L-DOPA CHEZ DES PATIENTS ATTEINTS DE SYNDROMES PARKINSONIENS, DEPRESSIFS OU MANIAQUES SOUS L-DOPA EN PERFUSION COMBINEE OU NON A UN INHIBITEUR DE LA DECARBOXYLASE. EFFETS PHARMACOLOGIQUESGEISSBUHLER F; EISENRING JJ; FRIEDLI P et al.1972; ENCEPHALE; FR.; DA. 1972; VOL. 61; NO 2; PP. 127-148; BIBL. 14 REF.Serial Issue

EFFECT OF CLONIDINE ON UTILIZATION AND POTASSIUM-EVOKED RELEASE OF ADRENALINE IN RAT BRAIN AREASSCATTON B; PELAYO F; DUBOCOVICH ML et al.1979; BRAIN RES.; NLD; DA. 1979; VOL. 176; NO 1; PP. 197-201; BIBL. 21 REF.Article

EFFECTS OF CLOZAPINE ON CEREBRAL CATECHOLAMINERGIC NEURONE SYSTEMSBARTHOLINI G; HAEFELY W; JALFRE M et al.1972; BRIT. J. PHARMACOL.; G.B.; DA. 1972; VOL. 46; NO 4; PP. 736-740; BIBL. 13 REF.Serial Issue

ABSENCE OF DEGENERATION OF ADRENERGIC NEURONS AFTER PROLONGED TREATMENT WITH DEBRISOQUIN = L'ABSENCE DE DEGENERESCENCE DES NEURONES ADRENERGIQUES APRES UN TRAITEMENT PROLONGE PAR LA DEBRISOQUINEHAEUSLER G; LOREZ HP; BARTHOLINI G et al.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 189; NO 3; PP. 646-658; BIBL. 1P.Article

EFFECT OF SPREADING DEPRESSION ON ELECTRICAL ACTIVITY AND DOPAMINE TURNOVER IN THE STRIATUM OF RATS = ACTION DE LA DEPRESSION ENVAHISSANTE CORTICALE SUR L'ACTIVITE ELECTRIQUE ET LE RENOUVELLEMENT DE LA DOPAMINE DANS LE STRIATUM DE RATSPIERI L; BARTHOLINI G; KELLER HH et al.1973; EXPERIENTIA; SUISSE; DA. 1973; VOL. 29; NO 4; PP. 452-454; ABS. ALLEM.; BIBL. 21REF.Serial Issue

GAMMA -AMINOBUTYRIC ACID (GABA) RECEPTOR STIMULATION. I: NEUROPHARMACOLO-PROFILES OF PROGABIDE (SL 76002) AND SL 75102, WITH EMPHASIS ON THEIR ANTICONVULSANT SPECTRAWORMS P; DEPOORTERE H; DURAND A et al.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 3; PP. 660-671; BIBL. 65 REF.Article

Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmissionZIVKOVIC, B; OBLIN, A; BARTHOLINI, G et al.European journal of pharmacology. 1985, Vol 112, Num 2, pp 253-255, issn 0014-2999Article